Q2 2025 · 13F-HR
Matrix Capital Management Company, LPholdings as filed
Filed 2025-08-14 · accession 0001172661-25-003340
$222.8M
Reported value
4
Positions
2025-06-30
Period end
The Brief · Matrix Capital Management Company, LP · Q2 2025
AI · grounded in 13F
Matrix Capital Management Company, LP established four new positions to reach a total AUM of $222.8M. The fund's largest move was a new position in GlobalFoundries Inc GFS valued at $132.7M. Other new entries include Aura Biosciences Inc AURA at $43.3M and Maze Therapeutics Inc MAZE at $30.5M. The fund also added Zentalis Pharmaceuticals Inc ZNTL with a position of $16.2M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| G39387108 | GFS | GLOBALFOUNDRIES INC | $132.7M | 59.6% | 3,475,000 | Common | SOLE |
| 05153U107 | AURA | AURA BIOSCIENCES INC | $43.3M | 19.5% | 6,922,870 | Common | SOLE |
| 578784100 | MAZE | MAZE THERAPEUTICS INC | $30.5M | 13.7% | 2,486,184 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $16.2M | 7.27% | 13,959,973 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.